» Go to news main

QEII welcomes the first GE StarGuide SPECT‑CT scanner in Canada.

Posted by Angie Kinsman on June 3, 2024 in Nuclear Medicine
Left to right: Susan Mullin, president and CEO, QEII Foundation, Dr. Steven Burrell, head of nuclear medicine, QEII, Dr. James Clarke, chief of diagnostic imaging, Nova Scotia Health and Mike Hamilton, president of GE HealthCare Canada are picture with the StarGuide Hybrid SPECT/CT at the QEII Health Sciences Centre. (Uncharted Media)
Left to right: Susan Mullin, president and CEO, QEII Foundation, Dr. Steven Burrell, head of nuclear medicine, QEII, Dr. James Clarke, chief of diagnostic imaging, Nova Scotia Health and Mike Hamilton, president of GE HealthCare Canada are picture with the StarGuide Hybrid SPECT/CT at the QEII Health Sciences Centre. (Uncharted Media)

The first patients were scanned on this CZT ring-detector scanner in June 2024, and a second StarGuide will be installed in 2025. These state-of-the-art scanners provide important benefits in imaging of cardiac disease, cancer, and many other conditions, and facilitate theranostic applications. They have been funded by the generous support of donors through the QEII Foundation. Click here to learn more.